Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
SCP Ventures, LLC, founded in 2015, is based in the San Francisco Bay Area and evolved from the Sustainergy Capital model established in 2012. The firm manages a portfolio of 12 companies and focuses on early-stage healthcare investments, particularly in medical technologies and IT services. The partners leverage their extensive experience in the US and Asia to support portfolio companies in both domestic and international markets.
SCP Ventures invests in Seed, Series A, and Series B funding rounds, specifically targeting early-stage healthcare companies. The firm emphasizes medical technologies and IT services that can disrupt established industry verticals or address overlooked market segments. They also reserve capital for follow-on investments to support the growth of their portfolio companies.
Notable portfolio companies include Venclose, a medical technology company for chronic venous insufficiency; OrthoFX, which offers a clear aligner experience; Neptune Medical, focused on small intestine disease technologies; and Avenda Health, developing AI software for personalized prostate cancer therapy. Other companies include iDentical, Inc., Inhalon Biopharma, Inc., and FastWave Medical, Inc..
Email info@scpventuresllc.com with your deck to pitch SCP Ventures.
Yes, SCP Ventures typically leads funding rounds in their target sectors, particularly in early-stage healthcare investments.
The firm reserves capital for follow-on investments to support the growth of their portfolio companies, ensuring they can continue to scale effectively.
Specific fund size details are not disclosed, but the firm focuses on early-stage investments across multiple rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.